Alaya.bio, a biotechnology company developing a scalable polymeric delivery platform to precisely target and reprogram cells in situ, is pleased to announce an expanded collaboration with Michel ...
NEW YORK--(BUSINESS WIRE)--Alaya.bio, a biotechnology company developing a scalable polymeric delivery platform to precisely target and reprogram cells in situ, is pleased to announce an expanded ...
Dec. 12, 2024 — The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the ... Dec. 12, 2024 — The future of ...
When 3D printing was first introduced in 1985, it marked a major turning point for the manufacturing industry. In addition to ...
IRONMARKETS covers Caterpillar Inc's revival of fan-favorite Cat ® Trials program, celebrating the company's 100th year as ...
An IBEC-led study describes the development of an innovative method to control the formation of crypt-like structures and ...
An IBEC-led study describes the development of an innovative method to control the formation of crypt-like structures and ...
Using toolpath-optimized deposition-based methods, an team of researchers has proposed an innovative approach to 3D-print ...
In a recent study, scientists have introduced an innovative imaging technique that provides an unparalleled view of the bone marrow’s intricate ...